Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros

Nature Immunology

Volumn 14, Issue 10, 2013, Pages 1073-1083

  Schjerven, Hilde ^a   Mclaughlin, Jami ^a   Arenzana, Teresita L ^a   Frietze, Seth ^b   Cheng, Donghui ^a   Wadsworth, Sarah E ^a   Lawson, Gregory W ^a,c   Bensinger, Steven J ^a,c   Farnham, Peggy J ^b   Witte, Owen N ^a   Smale, Stephen T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 1; ZINC FINGER PROTEIN 4; ZINC FINGER PROTEIN C2H2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DNA BINDING; EMBRYO; FEMALE; GENE CONTROL; GENE FUNCTION; GENE TARGETING; IMMUNE SYSTEM; IMMUNOREGULATION; LEUKEMOGENESIS; LYMPHOPOIESIS; MALE; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN IMMUNOPRECIPITATION; CLUSTER ANALYSIS; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GERM-LINE MUTATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; IKAROS TRANSCRIPTION FACTOR; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; LYMPHOPOIESIS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NUCLEOTIDE MOTIFS; PHENOTYPE; POSITION-SPECIFIC SCORING MATRICES; PROTEIN BINDING; THYMOCYTES;

EID: 84886656087     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2707     Document Type: Article

References (53)

1. Wang, J.H. et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5, 537-549 (1996
2. Georgopoulos, K. Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat. Rev. Immunol. 2, 162-174 (2002
3. Yoshida, T., Ng, S.Y. & Georgopoulos, K. Awakening lineage potential by Ikaros-mediated transcriptional priming. Curr. Opin. Immunol. 22, 154-160 (2010
4. Yoshida, T., Ng, S.Y., Zuniga-Pflucker, J.C. & Georgopoulos, K. Early hematopoietic lineage restrictions directed by Ikaros. Nat. Immunol. 7, 382-391 (2006
5. Kirstetter, P., Thomas, M., Dierich, A., Kastner, P. & Chan, S. Ikaros is critical for B cell differentiation and function. Eur. J. Immunol. 32, 720-730 (2002
6. Thompson, E.C. et al. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 26, 335-344 (2007
7. Reynaud, D. et al. Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat. Immunol. 9, 927-936 (2008
8. Trageser, D. et al. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J. Exp. Med. 206, 1739-1753 (2009
9. Ma, S. et al. Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. Mol. Cell Biol. 30, 4149-4158 (2010
10. Winandy, S., Wu, P. & Georgopoulos, K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 83, 289-299 (1995
11. Dumortier, A. et al. Notch activation is an early and critical event during T-cell leukemogenesis in Ikaros-deficient mice. Mol. Cell Biol. 26, 209-220 (2006
12. Mullighan, C.G. et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 453, 110-114 (2008
13. Mullighan, C.G. et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N. Engl. J. Med. 360, 470-480 (2009
14. Kim, J. et al. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10, 345-355 (1999
15. Sridharan, R. & Smale, S.T. Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes. J. Biol. Chem. 282, 30227-30238 (2007
16. Zhang, J. et al. Harnessing of the nucleosome-remodeling-deacetylase complex controls lymphocyte development and prevents leukemogenesis. Nat. Immunol. 13, 86-94 (2011
17. Harker, N. et al. The CD8α gene locus is regulated by the Ikaros family of proteins. Mol. Cell 10, 1403-1415 (2002
18. Naito, T., Gomez-Del Arco, P., Williams, C.J. & Georgopoulos, K. Antagonistic interactions between Ikaros and the chromatin remodeler Mi-2β determine silencer activity and Cd4 gene expression. Immunity 27, 723-734 (2007
19. Gomez-del Arco, P. et al. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity 33, 685-698 (2010
20. Ng, S.Y., Yoshida, T., Zhang, J. & Georgopoulos, K. Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity 30, 493-507 (2009
21. John, L.B. & Ward, A.C. The Ikaros gene family: Transcriptional regulators of hematopoiesis and immunity. Mol. Immunol. 48, 1272-1278 (2011
22. Sun, L., Liu, A. & Georgopoulos, K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15, 5358-5369 (1996
23. Trinh, L.A. et al. Down-regulation of TDT transcription in CD4+CD8+ thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev. 15, 1817-1832 (2001
24. McCarty, A.S., Kleiger, G., Eisenberg, D. & Smale, S.T. Selective dimerization of a C2H2 zinc finger subfamily. Mol. Cell 11, 459-470 (2003
25. Tupler, R., Perini, G. & Green, M.R. Expressing the human genome. Nature 409, 832-833 (2001
26. Ravasi, T. et al. Systematic characterization of the zinc-finger- containing proteins in the mouse transcriptome. Genome Res. 13, 1430-1442 (2003
27. Klug, A. The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu. Rev. Biochem. 79, 213-231 (2010
28. Wolfe, S.A., Nekludova, L. & Pabo, C.O. DNA recognition by Cys2His2 zinc finger proteins. Annu. Rev. Biophys. Biomol. Struct. 29, 183-212 (2000
29. Molnar, A. & Georgopoulos, K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol. Cell Biol. 14, 8292-8303 (1994
30. Cobb, B.S. et al. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev. 14, 2146-2160 (2000
31. Koipally, J., Heller, E.J., Seavitt, J.R. & Georgopoulos, K. Unconventional potentiation of gene expression by Ikaros. J. Biol. Chem. 277, 13007-13015 (2002
32. Hahm, K. et al. Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev. 12, 782-796 (1998
33. Payne, K.J. et al. Ikaros isoform x is selectively expressed in myeloid differentiation. J. Immunol. 170, 3091-3098 (2003
34. Miller, J., McLachlan, A.D. & Klug, A. Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J. 4, 1609-1614 (1985
35. Shastry, B.S. Transcription factor IIIA (TFIIIA) in the second decade. J. Cell Sci. 109, 535-539 (1996
36. Filippova, G.N. et al. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes. Mol. Cell Biol. 16, 2802-2813 (1996
37. Ohlsson, R., Renkawitz, R. & Lobanenkov, V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet. 17, 520-527 (2001
38. Renda, M. et al. Critical DNA binding interactions of the insulator protein CTCF: A small number of zinc fingers mediate strong binding, and a single finger-DNA interaction controls binding at imprinted loci. J. Biol. Chem. 282, 33336-33345 (2007
39. Nurmemmedov, E., Yengo, R.K., Uysal, H., Karlsson, R. & Thunnissen, M.M. New insights into DNA-binding behavior of Wilms tumor protein (WT1)-a dual study. Biophys. Chem. 145, 116-125 (2009
40. Nakahashi, H. et al. A genome-wide map of CTCF multivalency redefines the CTCF code. Cell Rep. 3, 1678-1689 (2013
41. Hardy, R.R., Carmack, C.E., Shinton, S.A., Kemp, J.D. & Hayakawa, K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173, 1213-1225 (1991
42. Rolink, A., Grawunder, U., Winkler, T.H., Karasuyama, H. & Melchers, F. IL-2 receptor α chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6, 1257-1264 (1994
43. Rothenberg, E.V., Moore, J.E. & Yui, M.A. Launching the T-cell-lineage developmental programme. Nat. Rev. Immunol. 8, 9-21 (2008
44. Randall, T.D., Carragher, D.M. & Rangel-Moreno, J. Development of secondary lymphoid organs. Annu. Rev. Immunol. 26, 627-650 (2008
45. Juric, D. et al. Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias. J. Clin. Oncol. 25, 1341-1349 (2007
46. Lu, Q. delta-Catenin dysregulation in cancer: Interactions with E-cadherin and beyond. J. Pathol. 222, 119-123 (2010
47. Wang, H. et al. The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3. Tumour Biol. 31, 59-67 (2010
48. Perentes, J.Y. et al. Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors. Cancer Res. 71, 4527-4538 (2011
49. Marcais, A. et al. Genetic inactivation of Ikaros is a rare event in human T-ALL. Leuk. Res. 34, 426-429 (2010
50. Wong, S. et al. Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations. Proc. Natl. Acad. Sci. USA 101, 17456-17461 (2004
51. Papathanasiou, P. et al. Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. Immunity 19, 131-144 (2003
52. Lickwar, C.R., Mueller, F., Hanlon, S.W., McNally, J.G. & Lieb, J.D. Genome-wide protein-DNA binding dynamics suggest a molecular clutch for transcription factor function. Nature 484, 251-255 (2012
53. Virely, C. et al. Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia. Leukemia 24, 1200-1204 (2010